Your browser does not support the video tag.
Skip to content
home button
  • Resources
    • By Topic
      • Access to Clinical Trials
      • Artificial Intelligence
      • Clinical Trials Landscape
      • Data Collecting + Reporting
      • Ensuring Quality
      • Innovative Trials
      • Patient Engagement
      • Recruitment
      • Regulatory Submissions + Approvals
      • Safety
      • Site Planning
    • By Trial Stage
      • Study Design
        • Innovative Trials
        • Patient Group Engagement
        • Recruitment
      • Study Operations
        • Data Collecting
        • Regulatory Submissions + Approvals
        • Site Planning
  • Case Studies
  • About CTTI
  • Newsroom
  • Membership
  • Annual Report
connect with us
Signup for our Newsletter
  • About CTTI
  • Newsroom
  • Membership
  • Annual Report
Search

CTTI

Clinical Trials Transformation Initiative

Publications

Compliance with Results Reporting at ClinicalTrials.gov

Posted on March 12, 2015February 17, 2025 by Hannah Faulkner

Compliance with Results Reporting at ClinicalTrials.gov

Posted in Clinical Trials Landscape, Publications, Related: State of Clinical Trials, State of Clinical Trials, State of Clinical Trials Annual Report

The Clinical Trials Transformation Initiative: innovation through collaboration

Posted on October 31, 2014March 31, 2025 by Hannah Faulkner

The Clinical Trials Transformation Initiative: innovation through collaboration

Posted in Publications, State of Clinical Trials

Clinical Trials in Peripheral Vascular Disease: Pipeline and Trial Designs: An Evaluation of the ClinicalTrials.gov Database

Posted on September 19, 2014February 17, 2025 by Hannah Faulkner

Clinical Trials in Peripheral Vascular Disease: Pipeline and Trial Designs: An Evaluation of the ClinicalTrials.gov Database

Posted in Clinical Trials Landscape, Publications, Related: State of Clinical Trials, State of Clinical Trials, State of Clinical Trials Annual Report

Industry Practices for Expedited Reporting to Investigators Conducting Research Under an IND

Posted on May 1, 2014February 11, 2025 by Hannah Faulkner

Industry Practices for Expedited Reporting to Investigators Conducting Research Under an IND

Posted in Publications, Related: Safety Reporting, SAE Reporting, Safety, Safety Reporting, Study Operations

The Imperative of Overcoming Barriers to the Conduct of Large, Simple Trials

Posted on April 9, 2014February 6, 2025 by Hannah Faulkner

The Imperative of Overcoming Barriers to the Conduct of Large, Simple Trials

Posted in Innovative Trials, Large Simple Trials, Large Simple Trials, Publications, Related: Large Simple Trials, Study Design

Mini-Sentinel and Clinical Trials Transformation Initiative: Developing approaches to conducting randomized trials using the mini-sentinel distributed database

Posted on February 28, 2014February 5, 2025 by Hannah Faulkner

Mini-Sentinel and Clinical Trials Transformation Initiative: Developing approaches to conducting randomized trials using the mini-sentinel distributed database

Posted in Data Collecting and Reporting, Electronic Healthcare Data, Electronic Healthcare Data, Innovative Trials, Publications, Related: Electronic Healthcare Data, Study Design, Study Operations

Investigators’ Experience With Expedited Safety Reports Prior to the FDA’s Final IND Safety Reporting Rule

Posted on January 30, 2014February 11, 2025 by Hannah Faulkner

Investigators’ Experience With Expedited Safety Reports Prior to the FDA’s Final IND Safety Reporting Rule

Posted in Publications, Related: Safety Reporting, SAE Reporting, Safety, Safety Reporting, Study Operations

The Landscape of Clinical Trials in Nephrology: A Systematic Review of ClinicalTrials.gov

Posted on December 9, 2013February 17, 2025 by Hannah Faulkner

The Landscape of Clinical Trials in Nephrology: A Systematic Review of ClinicalTrials.gov

Posted in Clinical Trials Landscape, Publications, Related: State of Clinical Trials, State of Clinical Trials, State of Clinical Trials Annual Report

Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application

Posted on November 7, 2013February 11, 2025 by Hannah Faulkner

Optimizing Expedited Safety Reporting for Drugs and Biologics Subject to an Investigational New Drug Application

Posted in Publications, Related: Safety Reporting, SAE Reporting, Safety, Safety Reporting, Study Operations

Using ClinicalTrials.gov to Understand the State of Clinical Research in Pulmonary, Critical Care, and Sleep Medicine

Posted on October 16, 2013February 17, 2025 by Hannah Faulkner

Using ClinicalTrials.gov to Understand the State of Clinical Research in Pulmonary, Critical Care, and Sleep Medicine

Posted in Clinical Trials Landscape, Publications, Related: State of Clinical Trials, State of Clinical Trials, State of Clinical Trials Annual Report

Posts navigation

← Older posts
Newer posts →
 

DISCLAIMER: CTTI encourages the use of all materials listed on this site in the pursuit of improving the clinical trials enterprise. Our recommendations, tools, meeting summaries, and more are available to the public for free. We do ask that you acknowledge the source whenever using or referencing CTTI materials. Read our Citation Policy. 

  • About
  • Newsroom
  • Membership
  • Case Studies
  • Contact Us
  • Access to Clinical Trials
  • Artificial Intelligence
  • Clinical Trials Landscape
  • Data Collecting + Reporting
  • Ensuring Quality
  • Innovative Trials
  • Informed Consent
  • Patient Group Engagement
  • Real-World Data
  • Recruitment
  • Regulatory Submissions + Approvals
  • Safety + Protection
  • Site Planning
Sign up for our Newsletter
Log in

© Clinical Trials Transformation Initiative © 2026

terms of use

privacy statement

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.